Search by CAS No , Chemical Name or Molecular Formula
Long Term Storage
"Pramlintide (trade name Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). Pramlintide is sold as an acetate salt.",""
Pramlintide is an analogue of amylin, a small peptide hormone that is released into the bloodstream by the ß-cells of the pancreas along with insulin after a meal.
Taylor, Phil (19 December 2013);Jones MC (2007).
We normally respond within 8 hours.
This page contains information about Pramlintide Cas # 151126-32-8 and its API Standards.
Pramlintide Pramlintide Worldwide Suppliers of Pramlintide https://www.clearsynth.com/en/CSO30722.html API Standards Clearsynth 151126-32-8
Product rating: 9 Pramlintide based on 20 ratings
Keywords: API Standards CS-O-30722 Pramlintide Pramlintide 151126-32-8 3951.41 C171H269N51O53S2
Internal standard, Internal standard Pramlintide, HPLC-MS method validation, HPLC-MS method validation Pramlintide, LC-MS-MS method validation, LC-MS-MS method validation Pramlintide, Deuterated internal standard, Deuterated internal standard Pramlintide, Deuterated Pramlintide, Deuterium labeled Pramlintide, Quantitative bioanalytical methods, Quantitative bioanalytical methods Pramlintide, Blood samples Pramlintide, Blood concentrations, Heavy drugs, Analysis, Analysis Pramlintide, Clinical diagnostic, Clinical diagnostic Pramlintide, Dosing Pramlintide, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945